2025-2026 Regular Session • US Congress Legislature
HB4101: Cancer Drug Parity Act of 2025
Legislative Summary
To amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider.
Bill History
6/24/2025
Introduced in House
House of Representatives
6/24/2025
Referred to the House Committee on Education and Workforce.
House of Representatives
Status Information
Current Status
Introduced(6/24/2025)
Chamber
House of Representatives
Committee
Education and Workforce(House of Representatives)
Sponsors
Republican: 4
Democrat: 12
Primary Sponsor

Glenn Grothman
Republican
Co-Sponsors (15)
Suzanne Bonamici
Democrat
Gus Bilirakis
Republican
Brian Fitzpatrick
Republican
Joseph Morelle
Democrat
Doris Matsui
Democrat
Julia Brownley
Democrat
Gwen Moore
Democrat
Donald Davis
Democrat
Sharice Davids
Democrat
Joe Wilson
Republican
Timothy Kennedy
Democrat
Kathy Castor
Democrat
Jamie Raskin
Democrat
Eleanor Norton
Democrat
Becca Balint
Democrat